| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Jan 25 | XLO Xilio Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 16,625 | 0.00 | 16,625 |
| 1 Jan 25 | XLO Xilio Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.955 | 200,000 | 191.00 k | 200,000 |
| 1 Jan 25 | XLO Xilio Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 16,625 | 0.00 | 49,875 |
| 1 May 24 | XLO Xilio Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.08 | 59,333 | 64.08 k | 59,333 |
| 1 Jan 24 | XLO Xilio Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 66,500 | 0.00 | 66,500 |
| 5 Sep 23 | XLO Xilio Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.79 | 106,000 | 295.74 k | 106,000 |
